Carlos E Milla
Overview
Explore the profile of Carlos E Milla including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
62
Citations
1494
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Kratochvil M, Kaber G, Demirdjian S, Cai P, Burgener E, Nagy N, et al.
medRxiv
. 2022 Apr;
PMID: 35411348
Thick, viscous respiratory secretions are a major pathogenic feature of COVID-19 disease, but the composition and physical properties of these secretions are poorly understood. We characterized the composition and rheological...
12.
Joo N, Cho H, Shinbashi M, Choi J, Milla C, Engelhardt J, et al.
Sci Rep
. 2021 Sep;
11(1):18828.
PMID: 34552115
Mucus clearance, a primary innate defense mechanism of airways, is defective in patients with cystic fibrosis (CF) and CF animals. In previous work, the combination of a low dose of...
13.
Cai P, Krajina B, Kratochvil M, Zou L, Zhu A, Burgener E, et al.
Soft Matter
. 2021 Jan;
17(7):1929-1939.
PMID: 33427280
We present a method for using dynamic light scattering in the single-scattering limit to measure the viscoelastic moduli of soft materials. This microrheology technique only requires a small sample volume...
14.
Spano J, Milla C
Am J Respir Crit Care Med
. 2020 Nov;
203(8):937-939.
PMID: 33181036
No abstract available.
15.
Kratochvil M, Kaber G, Cai P, Burgener E, Barlow G, Nicolls M, et al.
medRxiv
. 2020 Sep;
PMID: 32935110
Thick, viscous respiratory secretions are a major pathogenic feature of COVID-19 disease, but the composition and physical properties of these secretions are poorly understood. We characterized the composition and rheological...
16.
Burgener E, Secor P, Tracy M, Sweere J, Bik E, Milla C, et al.
Phage (New Rochelle)
. 2020 Jul;
1(2):100-108.
PMID: 32626852
There is increasing interest in the pulmonary microbiome's bacterial and viral communities, particularly in the context of chronic airway infections in cystic fibrosis (CF). However, the isolation of microbial DNA...
17.
Secor P, Burgener E, Kinnersley M, Jennings L, Roman-Cruz V, Popescu M, et al.
Front Immunol
. 2020 Mar;
11:244.
PMID: 32153575
Pf bacteriophage are temperate phages that infect the bacterium , a major cause of chronic lung infections in cystic fibrosis (CF) and other settings. Pf and other temperate phages have...
18.
Vaidyanathan S, Salahudeen A, Sellers Z, Bravo D, Choi S, Batish A, et al.
Cell Stem Cell
. 2019 Dec;
26(2):161-171.e4.
PMID: 31839569
Cystic fibrosis (CF) is a monogenic disorder caused by mutations in the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) gene. Mortality in CF patients is mostly due to respiratory sequelae. Challenges...
19.
Malkovskiy A, Yacob A, Dunn C, Zirbes J, Ryan S, Bollyky P, et al.
Anal Chem
. 2019 May;
91(12):7929-7934.
PMID: 31117414
Improved methods are needed to reliably assess Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) function in vivo in light of recent therapeutic developments targeting the CFTR protein. Oral fluid from patients...
20.
Burgener E, Sweere J, Bach M, Secor P, Haddock N, Jennings L, et al.
Sci Transl Med
. 2019 Apr;
11(488).
PMID: 30996083
Filamentous bacteriophage (Pf phage) contribute to the virulence of infections in animal models, but their relevance to human disease is unclear. We sought to interrogate the prevalence and clinical relevance...